• Eastman Chemical forecasts full-year 2026 adjusted earnings of $6.00 to $6.20 per share.
• Operating cash flow is expected to reach about $850 million, including an anticipated fourth-quarter working capital release of about $250 million.
• Cost savings remain on track at $125 million to $150 million, net of inflation, with volume/mix growth expected around 3%.
• Capital spending is projected at about $400 million, roughly $150 million below 2025.
• The outlook faces inflationary pressure from the Middle East conflict; third-quarter adjusted EPS rose to $1.84 from $1.14 a year earlier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eastman Chemical Company published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.